Skip to main content
Year archive

AMPLIA THERAPEUTICS LIMITED — 2024 filings

All 100 regulatory filings released by AMPLIA THERAPEUTICS LIMITED (ATX) in 2024, sourced directly from the official regulator.

100 Filings
2024 Period
2024 filings (100)
Filing Released Lang
Security Class Reinstatement to Quotation - ATXOA 1
Regulatory Filings
2024-12-22 English
Notification regarding unquoted securities - ATX 6 pages 20.5KB
Share Issue/Capital Change
2024-12-19 English
Application for quotation of securities - ATX 6 pages 18.2KB
Share Issue/Capital Change
2024-12-19 English
Application for quotation of securities - ATX 6 pages 18.3KB
Share Issue/Capital Change
2024-12-19 English
Top 20 Holders and Range of Units for Attaching Options 4 pages 179.7KB
Major Shareholding Notification
2024-12-19 English
Change of Director's Interest Notice - Ms Jane Bell 4 pages 279.2KB
Director's Dealing
2024-12-19 English
Change of Director's Interest Notice - Dr Robert Peach 4 pages 319.1KB
Director's Dealing
2024-12-19 English
Change of Director's Interest Notice - Dr Chris Burns 4 pages 316.4KB
Director's Dealing
2024-12-19 English
Change of Director's Interest Notice - Dr Warwick Tong 4 pages 318.9KB
Director's Dealing
2024-12-19 English
Section 708A(5)(e) Notice - Allotment of 2,826,087 Shares 2 pages 215.3KB
Capital/Financing Update
2024-12-19 English
Results of Meeting - EGM 19 Dec 2024 2 pages 177.4KB
Declaration of Voting Results & Voting Rights Announcements
2024-12-18 English
Positive Data Strong Recruitment in Pancreatic Cancer Trial 2 pages 190.2KB
Capital/Financing Update
2024-12-10 English
Application for quotation of securities - ATX 5 pages 16.9KB
Share Issue/Capital Change
2024-11-27 English
Successful Completion of Retail Entitlement Offer 3 pages 202.3KB
Capital/Financing Update
2024-11-26 English
App 4D and Financial Report Half Year ended 30 Sep 2024 26 pages 1.4MB
Interim / Quarterly Report
2024-11-26 English
Change in substantial holding 3 pages 89.7KB
Major Shareholding Notification
2024-11-26 English
Security Class Suspension from Quotation 1 page 438
Regulatory Filings
2024-11-24 English
Notice of Extraordinary General Meeting/Proxy Form 30 pages 709.7KB
Proxy Solicitation & Information Statement
2024-11-17 English
Amplia Enters into Preclinical Collaboration 2 pages 178.1KB
Regulatory Filings
2024-11-13 English
Change in substantial holding 4 pages 183.3KB
Regulatory Filings
2024-11-07 English
Section 708A(5)(e) Notice - Allotment of 67,723,015 Shares 2 pages 214.9KB
Capital/Financing Update
2024-11-06 English
Application for quotation of securities - ATX 5 pages 16.8KB
Share Issue/Capital Change
2024-11-05 English
Substantial Holder Notice - Blueflag Holding Pty Ltd 2 pages 110.3KB
Regulatory Filings
2024-11-05 English
Proposed issue of securities - ATX 5 pages 18.6KB
Capital/Financing Update
2024-11-04 English
Amplia Successfully Completes Institutional Offer 4 pages 225.3KB
Capital/Financing Update
2024-10-31 English
Replacement Prospectus 63 pages 884.9KB
Capital/Financing Update
2024-10-31 English
Update - Proposed issue of securities - ATX 12 pages 42.8KB
Capital/Financing Update
2024-10-31 English
Proposed issue of securities - ATX 5 pages 19.3KB
Capital/Financing Update
2024-10-30 English
Trading Halt 2 pages 569.4KB
Capital/Financing Update
2024-10-29 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 390.3KB
Interim / Quarterly Report
2024-10-29 English
Interim Data From Accent Pancreatic Cancer Trial 10 pages 971.9KB
Capital/Financing Update
2024-10-29 English
Amplia to Raise up to $13m for ACCENT and US Trials 7 pages 354.1KB
Capital/Financing Update
2024-10-29 English
Capital Raise Presentation 48 pages 3.2MB
Investor Presentation
2024-10-29 English
Capital Raise Prospectus 57 pages 786.7KB
Capital/Financing Update
2024-10-29 English
Proposed issue of securities - ATX 6 pages 22.7KB
Capital/Financing Update
2024-10-29 English
Proposed issue of securities - ATX 12 pages 43.4KB
Capital/Financing Update
2024-10-29 English
Recruitment Restarts in ACCENT Pancreatic Cancer Trial 2 pages 182.7KB
Regulatory Filings
2024-10-15 English
Sixth Confirmed Response in Pancreatic Cancer Trial 2 pages 187.2KB
Capital/Financing Update
2024-09-22 English
FDA Fast Track Designation for Narmafotinib 2 pages 176.2KB
Regulatory Filings
2024-09-19 English
Application for quotation of securities - ATX 7 pages 21.1KB
Share Issue/Capital Change
2024-08-25 English
Change of Director's Interest Notice - Dr Chris Burns 3 pages 313.0KB
Director's Dealing
2024-08-25 English
Managing Director AGM Presentation 30 pages 13.7MB
AGM Information
2024-08-22 English
Results of Annual General Meeting 2 pages 160.9KB
Declaration of Voting Results & Voting Rights Announcements
2024-08-22 English
Fifth Confirmed Response in ACCENT Trial 2 pages 189.0KB
Regulatory Filings
2024-08-20 English
Amplia Receives R&D Tax Rebate Totalling $3.2 Million 1
Capital/Financing Update
2024-08-11 English
Change in substantial holding 5 pages 198.9KB
Regulatory Filings
2024-08-11 English
Ceasing to be a substantial holder from SOL 6 pages 575.3KB
Major Shareholding Notification
2024-08-08 English
Ceasing to be a substantial holder from PCG 2 pages 460.1KB
Major Shareholding Notification
2024-08-07 English
Granting of Key Patent in Europe and Japan 2 pages 175.9KB
Capital/Financing Update
2024-08-06 English
Additional Patient Response in Pancreatic Cancer Trial 2 pages 186.5KB
Capital/Financing Update
2024-08-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 396.2KB
Interim / Quarterly Report
2024-07-30 English
Sustained Reduction in Tumour Size Seen In Pancreatic Trial 2 pages 185.6KB
Regulatory Filings
2024-07-24 English
Notice of Annual General Meeting/Proxy Form 20 pages 627.2KB
AGM Information
2024-07-21 English
Proposed issue of securities - ATX 5 pages 18.2KB
Capital/Financing Update
2024-07-21 English
Application for quotation of securities - ATX 6 pages 18.4KB
Share Issue/Capital Change
2024-07-18 English
Section 708A Cleansing Notice 1 page 138.5KB
Share Issue/Capital Change
2024-07-18 English
Application for quotation of securities - ATX 7 pages 20.7KB
Share Issue/Capital Change
2024-07-16 English
Proposed issue of securities - ATX 5 pages 17.6KB
Share Issue/Capital Change
2024-07-16 English
Bioshares Conference Presentation 30 pages 11.3MB
Investor Presentation
2024-07-11 English
First 26 Patients recruited in Phase 2A ACCENT Trial 2 pages 183.9KB
Regulatory Filings
2024-07-02 English
Annual General Meeting to be held Friday 23 August 2024 1
AGM Information
2024-07-01 English
Notification of cessation of securities - ATX 4 pages 14.9KB
Share Issue/Capital Change
2024-06-24 English
Change of Director's Interest Notice - Dr Robert Peach 3 pages 313.3KB
Director's Dealing
2024-06-19 English
Presentation and Webinar 28 pages 5.4MB
Regulatory Filings
2024-06-10 English
Amplia Establishes World Class Clinical Advisory Board 2 pages 173.4KB
Board/Management Information
2024-06-02 English
Preliminary Final Report and Annual Report YE 31 March 2024 75 pages 18.2MB
Annual Report
2024-05-29 English
2024 Corporate Governance Statement 15 pages 423.8KB
Governance Information
2024-05-29 English
Appendix 4G - Key to Corporate Governance Disclosures 14 pages 394.3KB
Governance Information
2024-05-29 English
ASCO Conference Abstract 2 pages 179.2KB
Regulatory Filings
2024-05-23 English
Change of Director's Interest Notice - Chris Burns 3 pages 310.7KB
Director's Dealing
2024-05-20 English
Change of Director's Interest Notice - Jane Bell 3 pages 274.3KB
Director's Dealing
2024-05-20 English
Change of Director's Interest Notice - Dr Robert Peach 3 pages 313.3KB
Director's Dealing
2024-05-20 English
Becoming a substantial holder from PCG 3 pages 155.7KB
Regulatory Filings
2024-05-15 English
Change in substantial holding 5 pages 212.2KB
Regulatory Filings
2024-05-15 English
Notification regarding unquoted securities - ATX 7 pages 21.8KB
Share Issue/Capital Change
2024-05-15 English
Becoming a substantial holder from SOL 7 pages 1.1MB
Major Shareholding Notification
2024-05-15 English
$4.27m Offer Successfully Completed and ACCENT Trial Update 3 pages 198.8KB
Capital/Financing Update
2024-05-14 English
Application for quotation of securities - ATX 6 pages 18.2KB
Share Issue/Capital Change
2024-05-14 English
Substantial Holder Notice - Blueflag Holding Pty Ltd 2 pages 113.0KB
Regulatory Filings
2024-05-14 English
Notification of cessation of securities - ATX 4 pages 14.9KB
Share Issue/Capital Change
2024-05-12 English
Quarterly Activities/Appendix 4C Cash Flow Report 7 pages 389.9KB
Interim / Quarterly Report
2024-04-29 English
Entitlement Offer - Offer Booklet 73 pages 6.8MB
Regulatory Filings
2024-04-23 English
Fully Underwritten 2 for 5 Entitlement Offer to raise $4.27 4 pages 194.3KB
Capital/Financing Update
2024-04-15 English
Rights Issue Investor Slide Deck 45 pages 6.4MB
Regulatory Filings
2024-04-15 English
Entitlement Offer Cleansing Statement 2 pages 207.9KB
Capital/Financing Update
2024-04-15 English
Proposed issue of securities - ATX 7 pages 25.3KB
Capital/Financing Update
2024-04-15 English
Trading Halt 2 pages 225.3KB
Capital/Financing Update
2024-04-11 English
AACR Conference Presentation 3 pages 876.1KB
Investor Presentation
2024-04-09 English
Update on ACCENT Trial in Pancreatic Cancer 2 pages 185.3KB
Regulatory Filings
2024-03-26 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 413.8KB
Interim / Quarterly Report
2024-01-29 English
FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US 2 pages 175.2KB
Regulatory Filings
2024-01-17 English
Amplia Reports First Patient Dosing In Phase 2a Accent Trial 2 pages 183.5KB
Regulatory Filings
2024-01-16 English
Pause in Trading 1 page 117.2KB
Regulatory Filings
2024-01-16 English
Trading Halt 2 pages 562.1KB
Regulatory Filings
2024-01-16 English
Application for quotation of securities - ATX 6 pages 28.0KB
Share Issue/Capital Change
2024-01-01 English
Notification of cessation of securities - ATX 4 pages 23.9KB
Regulatory Filings
2024-01-01 English
Change of Director's Interest Notice - Jane Bell 3 pages 274.7KB
Director's Dealing
2024-01-01 English
Change of Director's Interest Notice - Dr Robert Peach 3 pages 315.0KB
Director's Dealing
2024-01-01 English
Change of Director's Interest Notice - Dr Chris Burns 3 pages 312.5KB
Director's Dealing
2024-01-01 English
Change of Director's Interest Notice - Dr Warwick Tong 3 pages 313.7KB
Director's Dealing
2024-01-01 English